CrossProfit
View CrossProfit's Articles BY TICKER:
AA,
AAPL,
ABC,
ABK,
ABT,
ADM,
AMZN,
ANDW,
ANSW,
ATHR,
ATI,
BA,
BAC,
BEAS,
BMY,
BOBJ,
BSC,
BTU,
CAH,
CCU,
CFC,
CHP,
CLF,
CNX,
COP,
CRAI,
CTV,
CVX,
DELL,
DJ,
ELOS,
EMITF,
EPAX,
ESV,
EXM,
FCX,
FDX,
FRX,
IBM,
IMCL,
ISLN,
ITB,
JPM,
LEH,
MBLX,
MCK,
MS,
MSFT,
MTL,
NCC,
NCR,
NE,
NEM,
NKE,
NOV,
NR,
NSM,
NTAP,
NUE,
NWS,
OMNI,
OMTR,
ORCL,
PKB,
PLD,
PTV,
RTH,
SAP,
SCT,
SMMX,
SPLS,
TEVA,
TGT,
TIF,
TLAB,
TLB,
TRI,
UIS,
VSEC,
WCG,
WEN,
WGOV,
WMT,
X,
XEL,
XHB,
XOM,
YHOO,
ZION
- Imclone Systems: No Shame, No Gain
- Zions Bankcorporation: Latest Analyst Ratings
- Talbots' Management Finally Puts Words Into Action
- Buying Lehman on Weakness Could Signal Renewed Faith
- Fedex Corp: It's All in the Name
- Archer Daniels Midland: New Equity Offer Signals Peak is Near
- Microsoft's Cashback: Changing the Internet Industry Forever
- Bank of America: Better Than Treasuries
- Distinction Between Hard and Soft Assets
- Bear Stearns, JPMorgan Deal Fallout Should Be Limited
- OMNI Energy Services: Why Buy More?
- Cleveland-Cliffs' Recent Correspondence
- Elbit Medical Imaging: Wrong Image!
- Ensco International: Buy Low and Hold
- ProLogis Lifts Full Year Forecast
- Puts of the Week: Ambassadors Group, Wellcare Health Plans
- Chevron Corporation: Time to Buy Abu Dhabi
- Cleveland-Cliffs, Inc.: Mining is Shining
- Mechel OAO: Earnings "Na Zdorovje" Style
- SAP, Oracle Turf War Far From Over
- Excel Maritime Carriers: Sailing Ahead on Global Trade Expansion
- ProLogis: Industrial Real Estate 'Holding' Value
- Gotta Love the Boeing Backlog
- Abbott Laboratories: In-Vitro Sale May Prove Difficult
- Ambac Financial: Sluggish EPS Growth on Lower Organic Earnings
- National Oilwell Varco: Looking Slick
- Countrywide Financial: Old vs. New Foreclosure Methods
- Wal-Mart Stores: Focusing on Home Growth
-
Staples: Accelerating Growth in a Decelerating Market
- Investing the Apple Way: A Long Term Strategy For Perfection
- Did Omniture Post a GAAP Profit or Loss?
- How Much is Andrew Corp. Worth? CommScope May Renegotiate Terms
